Detalhe da pesquisa
1.
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses.
Immunity
; 53(6): 1315-1330.e9, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33275896
2.
Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses.
Front Immunol
; 13: 992062, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36569949
3.
Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration.
Cell Death Dis
; 11(11): 973, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33184267